← Back to Analyst Consensus 
NERV Buy
Minerva Neurosciences, Inc.
Current Price —
Implied Upside —
Analysts 9
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 11, 2026 (16 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 14, 2026 | Jefferies | upgrade | Hold → Buy | — | 52% |
| Apr 15, 2026 | Citizens | initiate | — → Market Outperform | — | 47% |
| Mar 12, 2026 | HC Wainwright & Co. | maintain | Neutral → Neutral | — | 44% |
| Nov 6, 2025 | HC Wainwright & Co. | maintain | Neutral → Neutral | $4 | 44% |
| Feb 26, 2025 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $5 | 44% |
| Nov 6, 2024 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $5 | 44% |
| Aug 7, 2024 | HC Wainwright & Co. | maintain | Neutral → Neutral | $5 | 44% |
| May 2, 2024 | HC Wainwright & Co. | maintain | Neutral → Neutral | $7 | 44% |
| Feb 27, 2024 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $11 | 44% |
| Aug 2, 2023 | HC Wainwright & Co. | maintain | Neutral → Neutral | $11 | 44% |
| May 16, 2023 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $8 | 44% |
| May 2, 2023 | HC Wainwright & Co. | reiterate | — → Neutral | $8 | 44% |
| Mar 9, 2023 | HC Wainwright & Co. | reiterate | — → Neutral | $8 | 44% |
| Nov 10, 2022 | HC Wainwright & Co. | downgrade | Buy → Neutral | $0 | 44% |
| Oct 17, 2022 | JMP Securities | downgrade | Market Outperform → Market Perform | $0 | 53% |
Price Target Trend
Apr 1, 2026 Oct 26, 2026
EPS Estimates
+1q —
+1y —
0y —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days